| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f19a4868f531a964bedf65afc9c91a2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_574b1264d122800613debf4fb767cf12 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C10L2200-0476
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y203-0102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C10L2270-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C10L1-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8247 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-29 |
| filingDate |
2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37b1d4c8cdc8ac519367959bc6be4662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cf60c688037259df761db35afc67200
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_368b98dea628b3ee311aa72be39456b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80c59a4621ecd7cb4ddf4073bca9702a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_532e4275ccf2fab75f2871740205e771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dfa3349ac183f2b528db67d244ea669
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8bf70a7078656be91d26285e0da3d9 |
| publicationDate |
2022-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2889985-C |
| titleOfInvention |
Improved acyltransferase polynucleotides, polypeptides, and methods of use |
| abstract |
The invention provides chimeric DGAT1 proteins comprising: a) at their N-terminal ends, an N- terminal portion of a first DGAT1 protein, and b) at their C-terminal ends, a C-terminal portion of a second DGAT1 protein. The chimeric DGAT proteins show enhanced activity relative to at least one of the first DGAT1 protein and the second DGAT1 protein. The chimeric DGAT proteins of the invention can be expressed in cells to increase cellular lipid accumulation and/or modify the cellular lipid profile. The invention also provides polynucleotides encoding the chimeric DGAT1 proteins, cells and compositions comprising the polynucleotides or chimeric DGAT1 proteins, and methods using the chimeric DGAT1 proteins to produce oil. |
| priorityDate |
2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |